BPC-157



SKU BC10 Category

$55.00

Amino Acid Sequence:

Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val

Chemical Formula:

C₆₂H₉₈N₁₆O₂₂

CAS Registry Number:

137525‑51‑0

  • Tendon, ligament & muscle repair

  • Gastrointestinal protection

  • Neuroprotection & nerve regeneration

  • Angiogenesis & microvascular repair

  • Anti‑inflammatory modulation

  • Organ protection (liver, pancreas, cardiovascular tissues)

Key pathways observed in animal and in‑vitro research:

  • Modulation of nitric oxide signaling

  • Enhanced angiogenesis

  • Protection of endothelial and epithelial integrity

  • Support of microvascular stability

  • Anti‑inflammatory activity across multiple tissue types

Although there is extensive anecdotal evidence supporting research areas of interest, BPC‑157 is not FDA‑approved, and clinical trial human evidence remains limited and preliminary. Existing data are primarily from animal studies, in‑vitro research, and these anecdotal reports.

1. Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S., Perovic, D., Aralica, G., & Sikiric, P. (2003).
Gastric pentadecapeptide BPC‑157 accelerates healing of transected rat Achilles tendon. Journal of Orthopaedic Research, 21(5), 976–983.
2. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., Pang, J. H. S., & Sikiric, P. (2011).
Pentadecapeptide BPC‑157 enhances tendon‑to‑bone healing in a rat model. Journal of Applied Physiology, 110(3), 774–780.
3. Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D., Brcic, L., Sever, M., Klicek, R., Radic, B., & Drmic, D. (2010).
Pentadecapeptide BPC‑157 and angiogenesis. Current Pharmaceutical Design, 16(9), 1224–1232.
4. Sikiric, P., Seiwerth, S., Grabarevic, Z., Rucman, R., Petek, M., & Rotkvic, I. (1997).
The effect of pentadecapeptide BPC‑157 on inflammatory bowel disease. Journal of Physiology (Paris), 91(3–5), 173–178.
5. Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D., & Petek, M. (2001).
BPC‑157 and gastrointestinal mucosal integrity. Digestive Diseases and Sciences, 46(2), 385–392.
6. Hsieh, M. J., Liu, H. T., Wang, C. H., Chen, Y. H., & Lin, Y. C. (2017).
BPC‑157 improves peripheral nerve regeneration in rats. Neuroscience Letters, 644, 24–29.
7. Sikiric, P., Rucman, R., Turkovic, B., Sever, M., Klicek, R., Radic, B., Drmic, D., & Seiwerth, S. (2018).
BPC‑157 and the NO‑system: interactions and therapeutic potential. Current Pharmaceutical Design, 24(18), 1972–1989.
8. Vukojevic, J., Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Klicek, R., Drmic, D., & Sever, M. (2018).
Pentadecapeptide BPC‑157 mitigates multiple organ damage. Scientific Reports, 8, 1–15.


full product description

BPC‑157 (Body Protection Compound – 157) is a synthetic 15‑amino‑acid pentadecapeptide derived from a naturally occurring protective protein found in human gastric juice. It has been widely studied in preclinical research for its regenerative, angiogenic, and anti‑inflammatory properties. Although it is frequently discussed in sports medicine and regenerative‑medicine circles creating a large amount of anecdotal evidence, BPC‑157 is not FDA‑approved, and there are no large, controlled human clinical trials confirming its safety or efficacy.

In animal models, BPC‑157 has demonstrated accelerated healing of tendons, ligaments, muscle, nerves, and gastrointestinal tissues. Mechanistically, it appears to modulate nitric oxide signaling, enhance angiogenesis, and protect endothelial and epithelial integrity. These effects have led to growing scientific interest, though regulatory agencies emphasize that human evidence remains limited and preliminary.

BPC‑157 shows broad regenerative and anti‑inflammatory potential across multiple tissue types in preclinical studies. While human data remain limited, its multi‑system protective effects make it one of the most researched experimental peptides.

QUANTITY: 10 MG



Join Waitlist We will inform you when the product arrives in stock. Please leave your valid email address below.